Helius Medical Technologies (NASDAQ:HSDT) Trading Down 5.8% – Here’s Why

Helius Medical Technologies, Inc. (NASDAQ:HSDT)’s stock price dropped 5.8% during trading on Wednesday . The stock traded as low as $0.61 and last traded at $0.64. Approximately 121,735 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 6,598,582 shares. The stock had previously closed at $0.68.

Wall Street Analysts Forecast Growth

Separately, Maxim Group reiterated a “hold” rating on shares of Helius Medical Technologies in a research report on Wednesday, October 16th.

Helius Medical Technologies Stock Down 9.2 %

The company’s 50-day moving average is $0.68 and its 200-day moving average is $0.66. The stock has a market capitalization of $18.18 million, a price-to-earnings ratio of -0.09 and a beta of 1.50.

Helius Medical Technologies (NASDAQ:HSDT) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.99) EPS for the quarter. The firm had revenue of $0.05 million for the quarter. Helius Medical Technologies had a negative net margin of 1,764.74% and a negative return on equity of 244.82%.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.